Chemopreventive Effects of Nonsteroidal Anti-Inflammatory Drugs on 1,2-Dimethylhydrazine-Induced Colon Carcinogenesis in Rats

REFERENCES

• Bird R. P., Good C. K. The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol. Lett. 2000; 112–113; 395–402
   Google Scholar
• Bland P. W., Britton D. C. Colonic lymphoid tissue and its influence on tumour induction in dimethylhydrazine treated rats. Brit. J. Cancer. 1981; 44: 275–276
   Web of Science ®Google Scholar
• Borg D. C., Schaich K. M. Iron and hydroxyl radicals in lipid oxidation: Fenton reactions in lipid and nucleic acids co-oxidized with lipid. Oxy-radicals in Molecular Biology and Pathology, P.A. Cerutti, I. Fridovich, J.M. McCord. A. R. Liss, New York 1988; 427–441
   Google Scholar
• Cameron I. L., Garza J., Hardman W. E. Distribution of lymphoid nodules, aberrant crypt foci and tumours in the colon of carcinogen treated rats. Br. J. Cancer. 1996; 7: 893–898
   Google Scholar
• Carter J. W., Lancaster H. K., Hardman W. E., Cameron I. L. Distribution of intestine-associated lymphoid tissue, aberrant crypt foci, and tumors in the large bowel of 1,2-dimethylhydrazine treated mice. Cancer Res. 1994; 54: 4304–4307
   PubMed Web of Science ®Google Scholar
• Cejas P., Casado E., Belda-Iniesta C., Castro J. D., Espinosa E. Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain). Cancer Causes Control 2004; 15: 707–719
   PubMed Web of Science ®Google Scholar
• Craven P. A., Pfansteil J., DeRubertis F. R. Role of reactive oxygen in bile salt stimulation of colonic epithelial proliferation. J. Clin. Invest. 1986; 77: 850–859
   PubMed Web of Science ®Google Scholar
• Deasy J. M., Steele G., Ross D. S., Lahey S. J., Wilson R. E., Madara J. Gut associated lymphoid tissue and dimethylhydrazine-induced colorectal carcinoma in the Wistar/Furth rat. J. Surg. Oncol. 1983; 24: 36–40
   PubMed Web of Science ®Google Scholar
• DuBois R. N., Radhika A., Reddy B. S., Entingh A. J. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 1996; 110: 1259–1262
   PubMed Web of Science ®Google Scholar
• Earnest D. L., Hixson L. J., Alberts D. S. Piroxicam and other cycloxygenase inhibitors: potential for cancer chemoprevention. J. Cell Biochem. 1992; 161(Suppl)156–166
   Google Scholar
• Ikebuchi Y., Masumoto N., Tasaka K., Koike K., Kasahara K., Miyake A., Tanizawa O. Superoxide anion increases intracellular pH, intracellular free calcium, and arachidonate release in human amnion cells. J. Biol. Chem. 1991; 266: 13233–13237
   PubMedGoogle Scholar
• Jaruga P., Olinski R. Activity of antioxidant enzymes in cancer disease. Postery Hig. Med. Dosw. 1994; 48: 443–455
   PubMedGoogle Scholar
• Kawamori T., Rao C. V., Seibert K., Reddy B. S. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res. 1998; 56: 4566–4569
   Google Scholar
• Kelloff G. J., Boone C. W., Steele V. E., Crowell J. A., Lubet R., Sigman C. C. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials. Cancer Res 1994; 54: 2015s–2024s
   Google Scholar
• Kirkova M., Kassabova T., Russanov E. In vivo effects of indomethacin-I. Activity of antioxidant enzymes and lipid peroxidation. Gen. Pharmac. 1992; 23: 503–507
   PubMedGoogle Scholar
• Kono Y. Generation of superoxide radical during auto oxidation of hydroxylamine and an assay for superoxide dismutase. Arch. Biochem. Biophys. 1978; 186: 189–195
   PubMed Web of Science ®Google Scholar
• Laneuville O., Breuer D. K., Dewit D. L. Differential inhibition of human prostaglandin endoperoxides H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. Pharmacol. Exp. Ther. 1994; 271: 927–934
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosenbrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951; 64: 95–102
   Google Scholar
• Luck H. Methods of Enzymatic Analysis, H. U. Bergmeyer. Academic Press, New York 1971; 885–893
   Google Scholar
• Maffei F. R., Carini M., Aldini G., Saibene L., Maccocchi A. Antioxidant profile of nimesulide, indomethacin and diclofenac in phosphatidylcholine liposomes (PCL) as membrane model. Int. J. Tiss. React. 1993; 15: 225–234
   PubMedGoogle Scholar
• Marnett L. J. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res. 1992; 52: 5575–5589
   PubMed Web of Science ®Google Scholar
• Mates J. M., Perez-Gomez C., Nunez-deCastro I. Anti-oxidant enzymes and human diseases. Clin. Biochem. 1999; 32: 595–603
   PubMed Web of Science ®Google Scholar
• Mates M. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicity. Toxicology 2000; 153: 83–104
   PubMed Web of Science ®Google Scholar
• Melen-Mucha G., Niewiadomska H. Frequency of proliferation, apoptosis, and their ratio during rat colon carcinogenesis and their characteristic pattern in the dimethylhydrazine-induced colon adenoma and carcinoma. Cancer Invest 2002; 20: 700–712
   PubMed Web of Science ®Google Scholar
• Murrell G. A., Francis M. J., Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem. J. 1990; 265: 659
   PubMed Web of Science ®Google Scholar
• Noritsugu T., Yoshitsugu T., Amane K., Kenzo F., Tomoo K., Tamotsu K., Shinya O., Takashi K. Chemopreventive effect of a cycloxygenase-2-specific inhibitor (etodolac) on chemically induced biliary carcinogenesis in hamsters. Carcinogenesis 2005; 25: 465–469
   Google Scholar
• Oshima M., Dinchuk J. E., Kargman S. L., Oshima H., Hancock B., Kwong E., Trzaskos J. M., Evans J. F., Taketo M. M. Supressioin of intestinal polyposis in ApcΔ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996; 87: 803–809
   PubMed Web of Science ®Google Scholar
• Rao C. V., Desai D., Simi B., Kulkarni N., Amin S., Reddy B. S. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon. Cancer Res. 1993; 53: 4182–4188
   PubMed Web of Science ®Google Scholar
• Rigas B., Goldman I. S., Levine L. Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med. 1993; 122: 518–523
   PubMed Web of Science ®Google Scholar
• Sato K., Ito K., Kohara H., Yamaguchi Y., Adachi K., Endo H. Negative regulation of catalase gene expression in hepatoma cells. Mol. Cell. Biol. 1992; 12: 2525–2533
   PubMed Web of Science ®Google Scholar
• Shijun Li, Tao Y., Yang J. O., Oberley T. D., Oberley L. W. The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res. 2000; 60: 3927–3939
   PubMed Web of Science ®Google Scholar
• Stocks J., Dormandy T. L. The autooxidation of human red cell lipids induced by hydrogen peroxide. Br. J. Haematol. 1971; 20: 95–111
   PubMed Web of Science ®Google Scholar
• Tsuji M., DuBois R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthases-2. Cell 1995; 83: 493–501
   PubMed Web of Science ®Google Scholar
• Vane J., Botting R. Mechanism of action of anti-inflammatory drugs. Int. J. Tiss. React. 1998; 20: 3–15
   PubMedGoogle Scholar
• Vladimirov Y. A. Free radicals, antioxidant enzymes, and carcinogenesis. Free Radical Biol. Med. 1990; 8: 583–599
   Google Scholar
• Ward J. M. Morphogenesis of chemically induced neoplasms of the colon and small intestines in rats. Lab. Invest. 1974; 30: 505–513
   PubMed Web of Science ®Google Scholar